Tensegrity Pharma

Ten63 Therapeutics

This company develops small-molecule drugs for pharmaceutical partners and patients using a generative artificial intelligence and physics-based chemistry platform to treat undruggable protein targets.

IntrepidiaBio

This biopharmaceutical company develops therapeutic products to address unmet medical needs for patients.

Recursion Pharma

This company provides a technology platform for drug discovery and development to pharmaceutical partners and develops internal therapeutic candidates for patients with unmet medical needs.

Myosin Therapeutics

This biopharmaceutical company develops small molecule therapies targeting molecular nanomotors to treat aggressive cancers and neurological disorders for patients with unmet medical needs.

TargeGen

This company develops small molecule kinase inhibitors to treat blood disorders and inflammatory diseases for patients with unmet medical needs.

Momentous Therapeutics

This company develops pan-cancer drugs and therapeutic treatments for the pharmaceutical industry to address challenging biological targets.

Sequel Therapeutics

This pharmaceutical company develops and acquires medicines for patients in specific therapeutic areas.

Taveren Therapeutics

The company develops oncology drug candidates that reactivate natural tumour suppressors for pharmaceutical partners and cancer patients.